105 related articles for article (PubMed ID: 8790224)
1. Radiation absorbed dose from indium-111-CYT-356.
Mardirossian G; Brill AB; Dwyer KM; Kahn D; Nelp W
J Nucl Med; 1996 Sep; 37(9):1583-8. PubMed ID: 8790224
[TBL] [Abstract][Full Text] [Related]
2. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
[TBL] [Abstract][Full Text] [Related]
3. Radiation dose from human platelets labelled with indium 111.
van Reenen OR; Lötter MG; Minnaar PC; Heyns Adu P; Badenhorst PN; Pieters H
Br J Radiol; 1980 Aug; 53(632):790-5. PubMed ID: 6777011
[TBL] [Abstract][Full Text] [Related]
4. Primary lung cancer: biodistribution and dosimetry of two In-111-labeled monoclonal antibodies.
Brown PH; Krishnamurthy GT; Turner FE; Denney RK; Gilbert SA; Slauson ME
Radiology; 1989 Dec; 173(3):701-5. PubMed ID: 2510212
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution, radiation dosimetry and pharmacokinetics of 111In-antimyosin in idiopathic inflammatory myopathies.
Smith T; Senior R; Raval U; Dasgupta B; Lahiri A
J Nucl Med; 1999 Mar; 40(3):464-70. PubMed ID: 10086712
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and dosimetry of [111In] F(ab')2 fragments against prostatic acid phosphatase after intraprostatic injection for immunoscintigraphy in prostate cancer.
Nielsen JT; Poulsen J; Flø C; Marqversen J; Rehling M
Clin Physiol; 1995 Sep; 15(5):467-81. PubMed ID: 8846667
[TBL] [Abstract][Full Text] [Related]
7. MIRD dose estimate report No. 20: radiation absorbed-dose estimates for 111In- and 90Y-ibritumomab tiuxetan.
Fisher DR; Shen S; Meredith RF
J Nucl Med; 2009 Apr; 50(4):644-52. PubMed ID: 19289440
[TBL] [Abstract][Full Text] [Related]
8. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
9. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
[TBL] [Abstract][Full Text] [Related]
10. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes.
Mozley PD; Stubbs JB; Dresel SH; Barraclough ED; Smith T; Patel M; Finkelman C; Sparks RB; Thakur ML; Mathur A; Alavi A
J Nucl Med; 1999 Apr; 40(4):625-30. PubMed ID: 10210221
[TBL] [Abstract][Full Text] [Related]
11. Radiation dosimetry for indium-111-pentetreotide.
Stabin MG; Kooij PP; Bakker WH; Inoue T; Endo K; Coveney J; de Jong R; Minegishi A
J Nucl Med; 1997 Dec; 38(12):1919-22. PubMed ID: 9430470
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography.
Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR
Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer.
Buijs WC; Massuger LF; Claessens RA; Kenemans P; Corstens FH
J Nucl Med; 1992 Jun; 33(6):1113-20. PubMed ID: 1597725
[TBL] [Abstract][Full Text] [Related]
15. Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
Buijs WC; Oyen WJ; Dams ET; Boerman OC; Siegel JA; Claessens RA; van der Meer JW; Corstens FH
Nucl Med Commun; 1998 Aug; 19(8):743-51. PubMed ID: 9751928
[TBL] [Abstract][Full Text] [Related]
16. A compartmental model for biokinetics and dosimetry of 18F-choline in prostate cancer patients.
Giussani A; Janzen T; Uusijärvi-Lizana H; Tavola F; Zankl M; Sydoff M; Bjartell A; Leide-Svegborn S; Söderberg M; Mattsson S; Hoeschen C; Cantone MC
J Nucl Med; 2012 Jun; 53(6):985-93. PubMed ID: 22570328
[TBL] [Abstract][Full Text] [Related]
17. Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease.
Newberg AB; Wintering NA; Plössl K; Hochold J; Stabin MG; Watson M; Skovronsky D; Clark CM; Kung MP; Kung HF
J Nucl Med; 2006 May; 47(5):748-54. PubMed ID: 16644743
[TBL] [Abstract][Full Text] [Related]
18. Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.
Breitz HB; Fisher DR; Goris ML; Knox S; Ratliff B; Murtha AD; Weiden PL
Cancer Biother Radiopharm; 1999 Oct; 14(5):381-95. PubMed ID: 10850323
[TBL] [Abstract][Full Text] [Related]
19. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
Schmidt D; Langen KJ; Herzog H; Wirths J; Holschbach M; Kiwit JC; Ziemons K; Coenen HH; Müller-Gärtner H
Eur J Nucl Med; 1997 Sep; 24(9):1162-6. PubMed ID: 9283111
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution and dosimetry of indium-111-polyclonal IgG in normal subjects.
Datz FL; Castronovo FP; Christian PE; Anderson CE; Crebs K; Morton KA; Rauh DA
J Nucl Med; 1995 Dec; 36(12):2372-9. PubMed ID: 8523134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
